Discovery and Optimization of Thieno[2,3- d ]pyrimidine Inhibitors of NADH-Quinone Oxidoreductase (NuoD) as Medical Countermeasures against Francisella tularensis
ACS Infectious Diseases · 2026
DOI: 10.1021/acsinfecdis.5c00810 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2026. Verfasst von Zachary D Miller und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Development, Experimental Therapeutics Branch, Walter Reed Army Institute of Research (WRAIR), 503 Robert Grant Ave, Silver Spring…. Hauptthemen laut MEDLINE: Francisella tularensis, Anti-Bacterial Agents, Pyrimidines, Enzyme Inhibitors. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Oak Ridge Institute for Science and Education, Defense Threat Reduction Agency.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Development, Experimental Therapeutics Branch, Walter Reed Army Institute of Research (WRAIR), 503 Robert Grant Ave, Silver Spring, Maryland 20910, United States.
- Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, Maryland 21702, United States.
- Molecular Biology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, Maryland 21702, United States.
- Department of Drug Discovery, Experimental Therapeutics Branch, Walter Reed Army Institute of Research (WRAIR), 503 Robert Grant Ave, Silver Spring, Maryland 20910, United States.
ORCID-Profile: J Matthew Meinig, Joel A Bozue, Anthony L Handlon
Förderung
- Oak Ridge Institute for Science and Education
- Defense Threat Reduction Agency
Zitieren
APA
Miller, Z. D., Tao, B., Mlynek, K. D., Xander, C., Martinez, E. E., Richardson, J. B., Toothman, R. G., Meinig, J. M., Bozue, J. A., Roncal, N., Jin, X., Vuong, C., Dennis, W. E., Blount, C. A., Wright, H. D., & Handlon, A. L. (2026). Discovery and Optimization of Thieno[2,3- d ]pyrimidine Inhibitors of NADH-Quinone Oxidoreductase (NuoD) as Medical Countermeasures against Francisella tularensis. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00810
Vancouver
Miller ZD, Tao B, Mlynek KD, Xander C, Martinez EE, Richardson JB, et al. Discovery and Optimization of Thieno[2,3- d ]pyrimidine Inhibitors of NADH-Quinone Oxidoreductase (NuoD) as Medical Countermeasures against Francisella tularensis. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.5c00810
BibTeX
@article{Miller2026,
author = {Miller, Zachary D and Tao, Bin and Mlynek, Kevin D and Xander, Christian and Martinez, Elsie E and Richardson, Joshua B and Toothman, Ronald G and Meinig, J Matthew and Bozue, Joel A and Roncal, Norma and Jin, Xiannu and Vuong, Chau and Dennis, William E and Blount, Cameron A and Wright, Hannah D and Handlon, Anthony L},
title = {Discovery and Optimization of Thieno[2,3- d ]pyrimidine Inhibitors of NADH-Quinone Oxidoreductase (NuoD) as Medical Countermeasures against Francisella tularensis},
journal = {ACS Infectious Diseases},
year = {2026},
doi = {10.1021/acsinfecdis.5c00810}
}
EUVIMED